// App-Quantinova.ai

: PDCT-13. ENTRECTINIB IN CHILDREN AND ADOLESCENTS WITH RECURRENT OR REFRACTORY SOLID TUMORS INCLUDING PRIMARY CNS TUMORS

Researchers

Presenter

  • Brian Weiss

Principal Investigators

  • Mohamed Abdelbaki

  • Mufiza Farid-Kapadia

  • Georgina Meneses-Lorente

  • Alison Cardenas

  • Katherine Hutchinson

  • Guillaume Bergthold

  • Edna Chow Maneval

  • Elizabeth Fox

  • Amar Gajjar

Medical Centers

  • Hoffmann-La Roche Ltd, Mississauga, ON, Canada

  • Roche Products Ltd., Welwyn Garden City, United Kingdom

  • Genentech, South Sanfrancisco, CA.

  • F. Hoffmann-La Roche Ltd., Basel, Switzerland

  • Ignyta, Inc, San Diego, CA

  • St. Jude Children's Research Hospital, Memphis, TN

Locations

  • United States

  • Canada

  • United Kingdom

  • Switzerland

Companies

  • Feng Chi Biotech Cor

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Oncology (ONC)

Disease

  • Pulmonary edema

  • Solid malignancies

Biomarkers

  • Neurotrophic tropomyosin receptor kinase

  • Creatinine

Drug/Treatment

  • Entrectinib

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I/II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved